Filter Results
:
(264)
Show Results For
-
All HBS Web
(264)
- News (105)
- Research (112)
- Events (1)
- Multimedia (3)
- Faculty Publications (36)
Show Results For
-
All HBS Web
(264)
- News (105)
- Research (112)
- Events (1)
- Multimedia (3)
- Faculty Publications (36)
- March 2021 (Revised January 2023)
- Case
The Trouble with TCE
By: Vincent Pons, Rafael Di Tella and Galit Goldstein
Trichloroethylene, or TCE, was a chemical used by tens of thousands of businesses in the United States. It was an affordable tool for many. Yet, TCE had been associated with important health risks, including cancer and autoimmune disease. TCE potentially posed other...
View Details
Keywords:
Trichloroethylene;
Toxicity;
Lobbying;
Chemicals;
Health Disorders;
Governing Rules, Regulations, and Reforms;
Policy;
Ethics;
Business and Government Relations;
Chemical Industry;
United States
Pons, Vincent, Rafael Di Tella, and Galit Goldstein. "The Trouble with TCE." Harvard Business School Case 721-031, March 2021. (Revised January 2023.)
- Web
Curriculum - MBA
a systems-level, quantitative understanding of angiogenesis, extracellular matrix, metastatic process, delivery of drugs and immune cells, and response to conventional and novel therapies, including immunotherapies. Discussions will address challenges and future...
View Details
- 30 Nov 2016
- HBS Seminar
Melissa Valentine and Michael Bernstein, Stanford University
- Web
Faculty & Advisors - MBA
life-science tools and diagnostics, and she started her career as an analyst at MPM. She currently serves on the Harvard Medical School Board of Fellows and is a Trustee of the American Association for Cancer View Details
- January 2023
- Case
Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery
By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful...
View Details
Keywords:
Product Development;
Leadership;
Health Testing and Trials;
Research and Development;
Risk and Uncertainty;
Financial Condition;
Partners and Partnerships;
Pharmaceutical Industry
Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.
- Web
Value-Based Health Care - Institute For Strategy And Competitiveness
HBS ISC Health Care Health Care Value-Based Health Care Health Care Courses Fast Facts Value-Based Health Care Value-Based Health Care Cases & Teaching Notes Key Concepts Key Stakeholders Publications Team Work With Us Presentations Value-Based Health Care Based on the...
View Details
- March 2008 (Revised June 2008)
- Case
The Broad Institute: Applying the Power of Genomics to Medicine
By: Vicki L. Sato and Rachel Gordon
In June 2003, Harvard University and MIT announced an unprecedented partnership to create a biomedical institute, The Broad Institute. The culture of the Broad centered on science, and those involved considered it to be at the edge of the scientific frontier. In just...
View Details
Keywords:
Education;
Health Care and Treatment;
Innovation Leadership;
Growth and Development Strategy;
Organizational Culture;
Partners and Partnerships;
Research and Development;
Genetics
Sato, Vicki L., and Rachel Gordon. "The Broad Institute: Applying the Power of Genomics to Medicine." Harvard Business School Case 608-114, March 2008. (Revised June 2008.)
- 12 Dec 2022
- Research & Ideas
Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them
Black patients and their doctors may be more open to new medications if drug trials included more Black people, new research shows. Currently, Black Americans represent just 5 percent of drug trial participants. Nearly three-quarters of...
View Details
- 14 Dec 2020
- Research & Ideas
What Does December's Drug-Approval Dash Mean for COVID-19 Vaccines?
Pharmaceutical regulators around the world tend to speed through drug applications in December and before major national holidays, according to new research that might raise questions about COVID-19 vaccines and other treatments under...
View Details
- 01 Jun 2009
- Lessons from the Classroom
The Challenges of Investing in Science-Based Innovation
In economic downtimes, businesses are apt to cut R&D projects that don't promise a speedy return on investment. But take a cue from smart science-based businesses, which view the recession as an opportunity to stoke up research and...
View Details
- 30 Apr 2024
- Book
When Managers Set Unrealistic Expectations, Employees Cut Ethical Corners
In the 1990s, when Harvard Business School Professor Lynn S. Paine was researching and writing about examples of corporate misconduct, she hoped more businesses would take decisive action to root out fraud and other unethical behavior....
View Details
Keywords:
by Dina Gerdeman
- Web
Blavatnik Fellowship in Life Science Entrepreneurship - Health Care
offers Harvard Business School (HBS) alumni and Harvard-affiliated postdoctoral researchers the opportunity to advance new ventures around promising life science technologies and develop their leadership talents during a 12-month...
View Details
- Web
Named Fellowship Funds - Alumni
charitable and civic activities, and chairs the board of the Dana-Farber Cancer Institute. Josh was named a successor trustee of his alma mater, Yale University, in 2013. Anita supports nonprofits primarily focused on health, education,...
View Details
- 14 Jul 2009
- First Look
First Look: July 14
innovation in which an innovator uses several research inputs to invent a new good. These inputs, in turn, must be invented before they can be used by the final innovator. As a consequence, the degree of patent protection affects the...
View Details
Keywords:
Martha Lagace
- 20 Sep 2016
- First Look
September 20, 2016
growing body of research yields ample evidence that individuals’ behavior often reflects an apparent concern for moral considerations. Using a broad definition of morality—to include varied non-egoistic motivations such as fairness,...
View Details
Keywords:
Sean Silverthorne
- 01 Sep 2015
- First Look
First Look -- September 1, 2015
https://www.hbs.edu/faculty/Pages/item.aspx?num=49520 2015 Journal of Comparative Effectiveness Research Comparative Costs of Advanced Proton and Photon Radiation Therapies: Lessons from Time-driven Activity-based Costing in Head and Neck...
View Details
Keywords:
Sean Silverthorne
- 16 Feb 2016
- First Look
February 16, 2016
kidney transplant (11th), women's health (16th), heart (25th), and cancer (29th) as among the best in the nation. Its $292 million in National Institutes of Health research grants ranked ninth in the nation....
View Details
Keywords:
Sean Silverthorne
- Web
Organize Care Around Medical Conditions - Institute For Strategy And Competitiveness
teams and services that all manage aspects of breast cancer over the full cycle of care. This would be surgical oncologists, medical oncologists, radiation oncologists, reconstructive surgeons, pathologists, and radiologists. Specialized...
View Details
- 03 Oct 2023
- Research Event
Build the Life You Want: Arthur Brooks and Oprah Winfrey Share Happiness Tips
specifically his descriptions of the manifold research that's going on on happiness, did you yourself change your own definition of what happiness is? What did you what did you learn or change? Winfrey: What I learned is that days where...
View Details
Keywords:
by HBS Staff
- 01 Dec 2023
- News
Wide Horizon
attention of the CEO of Pfizer (which had unsuccessfully tried to develop suramin for cancer in the 1980s) to help him locate 14 boxes of relevant research data in a warehouse in Kalamazoo, Michigan. While...
View Details
Keywords:
Dan Morrell; Photos by Sarah Wilson